Stay updated on Nivolumab with Bevacizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the study record for a Phase 2 trial of nivolumab and bevacizumab in recurrent glioblastoma, including its design, eligibility criteria, and outcome measures, instead of a forbidden-access error.
    Difference
    52%
    Check dated 2026-11-08T14:31:32.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0; the study record remains unavailable behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:46:19.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    An NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T16:14:34.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T21:00:25.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:06:27.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.7.0 added. A large set of core study metadata, including investigators and locations, eligibility criteria, and study record details, was removed.
    Difference
    19%
    Check dated 2026-09-20T22:10:14.000Z thumbnail image

Stay in the know with updates to Nivolumab with Bevacizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.